GCC Business News reports Bahrain has cleared oral Wegovy for treating obesity, following the UAE in offering the pill form of the GLP-1 drug in the Gulf.
Recap by typeshit. Post by Instagram on Instagram.
BMO's Evan Seigerman expects US share losses to weigh on Ozempic sales, while the 25% CagriSema figure comes from a post-hoc subgroup, not the full trial's 22.7%.
Beauty companies are reportedly exploring products aimed at facial changes linked to rapid weight loss on GLP-1 drugs.
A search page for retatrutide news with no specific story attached, so there is little new beyond recent coverage.
2:06:48
A live Q&A stream from DOWNSIZED taking viewer questions about GLP-1 medications, including Zepbound, Wegovy and Foundayo.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
The oral version of Novo's GLP-1 is now cleared for obesity treatment in Bahrain, following the UAE as the Gulf's second approval.
Loading…